Impact of cardiomyocyte cell cycle activity on atrial structural and functional remodeling following myocardial infarction
心肌细胞细胞周期活性对心肌梗死后心房结构和功能重塑的影响
基本信息
- 批准号:10442795
- 负责人:
- 金额:$ 64.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-22 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:Acute myocardial infarctionAddressAdultAnatomyApoptosisAtrial FibrillationAtrial FunctionBacterial Artificial ChromosomesBlood capillariesCDKN2A geneCalciumCardiac MyocytesCell CycleCell Cycle ProgressionCell NucleusCellsChronicClinical ResearchComplexCoronaryCoronary arteryCytokinesisDataDevelopmentDilatation - actionElectrophysiology (science)ExhibitsFibrosisFrequenciesFunctional disorderGenetic ModelsHarvestHeartHeart AtriumHumanHypertrophyImageImmuneIndividualInfarctionInfiltrationInjuryInterventionKineticsLaboratoriesLaser Scanning MicroscopyLeftLeft Atrial FunctionLeft atrial structureLigationLocationMechanicsMediatingMitosisModelingMolecularMusMyocardialMyocardial InfarctionMyocardiumOpticsOrganPathologicPatientsPhosphotransferasesPlayPredispositionProcessRattusReporterReportingRodentRoleS phaseSecondary toSurfaceSystemTestingTherapeutic InterventionTissuesTransgenesTransgenic MiceTransgenic OrganismsVascularizationVentricularWhole OrganismWild Type Mouseanillindensityevent cycleexperimental studyheart functionhemodynamicsimaging systeminhibitorinsightinterstitial cellmature animalmortalitymouse modelnerve supplynew therapeutic targetnovelpostnatalpreventresponsesham surgerytranscriptometwo-photonvoltage
项目摘要
Both experimental and clinical studies have demonstrated that chronic myocardial infarction is associated with
adverse remodeling of the left atrium, which in turn has an adverse impact on left atrial function. Left atrial
dilatation is a powerful and independent predictor of mortality after myocardial infarction, but the mechanisms
underlying the remodeling process are only poorly understood. Surprisingly, we have observed very high rates
of cardiomyocyte cell cycle activity in the left atrium of infarcted mice. However, the role that cardiomyocyte cell
cycle activity plays in mitigating or exacerbating structural and/or functional remodeling following myocardial
infarction is not known. To directly address this question, we have generated a transgenic mouse model wherein
infarct-induced left atrial cell cycle activity is silenced secondary to p16-Ink4a (p16) expression (p16 is a potent
inhibitor of the proliferative kinase Cdk4 and transgenic expression in adult animals has previously been shown
to be a potent cell cycle inhibitor). Here we propose to compare wild-type and p16 transgenic mice to determine
the impact of atrial cardiomyocyte cell cycle activation on left atrial structural and functional remodeling following
infarction. The experiments proposed in Aim 1 will determine the degree to which cardiomyocyte cell cycle activity
impacts structural atrial remodeling following myocardial infarction. Left atrial structural analyses will be
performed (a) at the tissue level to quantitate myocardial mass, cardiomyocyte number, fibrosis, immune cell
infiltration, autonomic innervation and capillary density, (b) at the cardiomyocyte level to quantitate the extent of
cell cycle progression and cellular hypertrophy as well as frequency of cardiomyocyte apoptosis, and (c) at the
molecular level to quantitate transcriptome changes. The experiments proposed in Aim 2 will determine the
degree to which cardiomyocyte cell cycle activity impacts atrial function following myocardial infarction. Atrial
functional analyses will be performed (a) at whole organism level to quantitate echocardiographic and
hemodynamic parameters, (b) at the intact heart level to quantitate calcium and voltage transient parameters in
the left atrium (via optical mapping) and of cell clusters within the intact heart (via two-photon laser scanning
microscopy), and (c) at the isolated cell level to quantitate fractional shortening and calcium handling kinetics.
Importantly, cross-referencing the cell and molecular data from Aim 1 with the imaging and functional data from
Aim 2 should enable us to better determine which cell cycle-mediated changes have a relevant impact on cardiac
function. Such information may suggest interventions aimed at reversing compromised left atrial function in
infarcted hearts.
实验和临床研究均表明慢性心肌梗死与
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LOREN J FIELD其他文献
LOREN J FIELD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LOREN J FIELD', 18)}}的其他基金
Impact of cardiomyocyte cell cycle activity on atrial structural and functional remodeling following myocardial infarction
心肌细胞细胞周期活性对心肌梗死后心房结构和功能重塑的影响
- 批准号:
10612944 - 财政年份:2022
- 资助金额:
$ 64.12万 - 项目类别:
Sequence Variants Impacting Cardiomyocyte S-phase Activity in Inbred Mice Following Injury
序列变异影响近交小鼠损伤后心肌细胞 S 期活性
- 批准号:
10094879 - 财政年份:2021
- 资助金额:
$ 64.12万 - 项目类别:
Sequence Variants Impacting Cardiomyocyte S-phase Activity in Inbred Mice Following Injury
序列变异影响近交小鼠损伤后心肌细胞 S 期活性
- 批准号:
10550204 - 财政年份:2021
- 资助金额:
$ 64.12万 - 项目类别:
Sequence Variants Impacting Cardiomyocyte S-phase Activity in Inbred Mice Following Injury
序列变异影响近交小鼠损伤后心肌细胞 S 期活性
- 批准号:
10339328 - 财政年份:2021
- 资助金额:
$ 64.12万 - 项目类别:
Cardiomyocyte cell cycle activity in injured hearts
受伤心脏中心肌细胞的细胞周期活动
- 批准号:
9308377 - 财政年份:2017
- 资助金额:
$ 64.12万 - 项目类别:
Transgenic Reporters for Cardiac Growth and Regeneration
用于心脏生长和再生的转基因报告基因
- 批准号:
7844909 - 财政年份:2009
- 资助金额:
$ 64.12万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 64.12万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 64.12万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 64.12万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 64.12万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 64.12万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 64.12万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 64.12万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 64.12万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 64.12万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 64.12万 - 项目类别:
Research Grant














{{item.name}}会员




